Mechanistically, many chemotherapies cause DNA damage in cancer cells, which triggers senescence through ATM-CHK2 and ATR-CHK1 kinase-mediated activation of the interconnected p53-RB pathways [128, 129]. This evidence concerns the gene TP53 and cancer.